Blackstone and Bain make multi-billion dollar bid for Mitsubishi Chemical division
Global private equity firms Blackstone and Bain are reportedly in the final stages of bidding for Mitsubishi Tanabe Pharma, a subsidiary of Japan’s Mitsubishi Chemical Group, in a deal expected to be valued between $3bn and $3.5bn, according to a report by Reuters.


